20481 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems 9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D
Medicament for the Treatment of Pain and Inflammation
#1202Vision-protecting composition with prophylactic and therapeutic activity against diabetes or diabetic complications
#1203Treatment of Hyperproliferative Disorders Using Cardiac Glycosides
#1204Nutrient compositions and methods for enhanced effectiveness of the immune system
#1205USE OF CANTHAXANTHIN AND/OR 25-OH D3 FOR IMPROVED HATCHABILITY IN POULTRY
#1206METHODS OF IMMUNE OR HEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER, CANCER SYMPTOMS, OR THE SYMPTOMS OF CANCER TREATMENTS
#1207Vitamin preparation
#1208PUFA COVERED IMPLANTS
#1209COMPOSITION FOR THE REDUCTION OF DRIP LOSSES IN PORK
#1210Nutritional supplement for use under physiologically stressful conditions
#1211COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES
#1212USE OF VITAMIN D GLYCOSIDES AND SULFATES FOR TREATMENT OF DISEASE
#1213Dissolvable dietary supplement strip and methods for using the same
#1214PROCESS FOR THE PRODUCTION OF CALCIUM COMPOSITIONS IN A CONTINUOUS FLUID BED
#1215Stem cell/endothelial progenitor cell mobilization by nutraceutical formulations
#1216Pharmaceutical composition comprising a strontium salt, vitamin D and A cyclodextrin
#1217Method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin K
#1218Method of preventing Type 1 diabetes
#1219USE OF 25-HYDROXY VITAMIN D3 TO INCREASE MUSCLE MASS IN MAMMALS
#1220TREATING HYPERTENSION WITH 25-HYDROXYVITAMIN D3
#1221Use of Carbon-2-Modified-Vitamin D Analogs to Induce the Formation of New Bone
#1222Once-a-week administration of 25-hydroxy vitamin Dto sustain elevated steady-state pharmacokinetic blood concentration
#1223Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis
#1224COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#1225COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#1226METHODS AND KITS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE AND PREGNANCY-RELATED DISORDERS IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#1227COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION IN RECIPIENTS OF ARTIFICAL INSEMINATION
#1228Zeolite Formulation And Use Thereof For The Prevention And Therapy Of Diseases Caused By Infections With Herpes Simplex Virus Type 1 And Type 2
#1229Calcium Formate For Use As A Dietary Supplement
#1230Vitamin D compounds and methods for reducing ocular hypertension (OHT)
#1231Vitamin D3 and analogs thereof for treating alopecia
#1232COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3
#1233Methods useful for vitamin D deficiency and related disorders
#1234TREATING HYPERGLYCEMIA WITH 25-HYDROXYVITAMIN D3
#1235USE OF 25-HYDROXY-VITAMIN D3 TO AFFECT HUMAN MUSCLE PHYSIOLOGY
#1236COMBINED USE OF 25-HYDROXY-VITAMIN D3 AND VITAMIN D3 FOR IMPROVING BONE MINERAL DENSITY AND FOR TREATING OSTEOPORISIS
#1237Composition of Risedronate and Vitamin D3
#1238Method of Preventing Renal Disease and Treating Symptoms Thereof
#1239Therapeutical uses of inecalcitol
#1240Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosis
#1241DRUG-CONTAINING COMPOSITION
#1242Methods and compositions for treating thyroid-related medical conditions with reduced folates
#1243Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function
#1244Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis
#1245Composition for headache treatment
#1246Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
#1247Pharmaceutical composition comprising oleaginous ointments and vitamin D or its derivatives in the solubilized state
#1248PHARMACEUTICAL COMPOSITION INCLUDING A CORTICOSTEROID AND A VITAMIN D ANALOG HAVING IMPROVED STABILITY
#1249Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of the elderly
#1250ANTIMICROBIAL THERAPY
#1251COMPOSITIONS COMPRISING STRONTIUM AND USES THEREOF IN THE TREATMENT OR PREVENTION OF GINGIVITIS, PERIODONTITIS, PERIODONTITIS AS A MANIFESTATION OF SYSTEMIC DISEASES, AND NECROTIZING PERIODONTAL DISEASES
#1252Compositions and methods related to calcitriol
#1253Composition for reducing the level of glucose, malondialdehyde-modified LDL, homocysteine and/or C-reactive protein in blood
#1254Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein
#1255USE OF 25-HYDROXY VITAMIN D3 TO IMPROVE MALE ANIMAL FERTILITY
#1256Methods to treat and/or prevent mucositis
#1257METHOD OF DELIVERING NUTRIENTS
#1258THERAPEUTIC AGENT FOR VITILIGO AND METHOD OF ACCELERATING PIGMENTATION
#1259METHOD OF USING CALCITRIOL FOR TREATING INTRAOCULAR DISEASES ASSOCIATED WITH ANGIOGENESIS
#1260Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases
#1261Antibody targeting osteoclast-related protein Siglec-15
#1262VITAMIN D3 AND ANALOGS THEREOF FOR ALLEVIATING SIDE EFFECTS ASSOCIATED WITH CHEMOTHERAPY
#1263Rapidly Dissolving Vitamin Formulation and Methods of Using the Same
#1264Suppression of glial fibrillary acidic protein
#1265Composition Containing a Bisphosphonic Acid in Combination with Vitamin D
#1266COMPOSITION AND NUTRITIONAL SUPPLEMENTS FOR IMPROVING OCULAR HEALTH AND REDUCING OCULAR INFLAMMATORY RESPONSE
#1267FORMULATIONS COMPRISING VITAMIN D OR DERIVATIVES THEREOF
#1268Use of chitosans to increase nail growth rate
#1269Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
#1270METHODS FOR GENERATING MAMMALIAN MODELS OF ATOPIC DISEASES, AND SCREENING FOR THEIR TREATMENT
#1271Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions
#1272QUINAZOLINE INHIBITORS OF EGFR TYROSINE KINASE
#1273Nutritional supplement for use under physiologically stressful conditions
#1274Method of treating vitamin D insufficiency and deficiency
#1275USE OF GLUCOCORTICOIDS FOR TREATMENT OF CONGESTIVE HEART FAILURE
#1276Compositions and Methods for Treating and Preventing Cancer Using Analogs of Vitamin D
#127725-hydroxy Vitamin Dcompositions
#1278COMPOSITIONS AND METHODS FOR PROPHYLACTIC AND THERAPEUTIC SUPPLEMENTATION OF NUTRITION IN SUBJECTS
#1279Compositions and methods of the treatment of obesity and osteoporosis
#1280Method of inducing negative chemotaxis
#1281POLYAPHRON TOPICAL COMPOSITION WITH VITAMIN D
#1282Skin cancer prevention method and product
#1283Peptides, derivatives and analogs thereof, and methods of using same
#1284METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER
#1285INDUCTION OF INNATE IMMUNITY BY VITAMIN D3 AND ITS ANALOGS
#1286FOOD SUPPLEMENTATION COMPOSITION CONTAINING ONE OR MORE VITAMIN D3 COMPOUNDS AND ONE OR MORE MAGNESIUM SALTS
#1287METHOD OF TREATING AND PREVENTING HYPERPARATHYROIDISM WITH ACTIVE VITAMIN D ANALOGS
#1288POTENTIATION OF ERYTHROPOIETIN (EPO) ACTION BY MEMBRANE STEROID RECEPTOR AGONISTS
#1289Method and composition for postoperative wound healing
#1290Method for reducing the risk of spontaneous abortion in a human female subject
#1291NOVEL METHOD OF TREATMENT OF MALE SUB-FERTILITY
#1292PHARMACEUTICAL COMPOSITIONS CONTAINING ANHYDROUS CALCIPOTRIENE
#1293Nutrient System for Individualized Responsive Dosing Regimens
#1294Pharmanutrient Composition(s) and System(s) for Individualized, Responsive Dosing Regimens
#1295COMBINATION OF A LANTHANUM COMPOUND AND BONE ENHANCING AGENT FOR THE TREATMENT OF BONE DISEASES
#1296COMPOSITIONS AND METHODS FOR NUTRITION SUPPLEMENTATION
#1297METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DISORDERS
#1298Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin Dand 25-hydroxyvitamin D
#1299Pharmaceutical Combination
#1300Methods of Treating Osteoporosis and Secondary Hyperparathyroidism Using 20-Methyl, Gemini Vitamin D3 Compounds
#1301ILT3 and ILT4-related compositions and methods
#1302MICRONUTRIENT SUPPLEMENT WITH CALCIUM, VITAMIN D OR CALCIUM & VITAMIN D COMBINATION FOR PREMENSTRUAL SYNDROME, POSTPARTUM DEPRESSION, DEPRESSION AND PANIC ATTACKS
#1303Combination dosage forms and therapies for supporting bone health
#1304Method of Stimulating Proteoglycan Synthesis in Cells
#1305COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR MISCARRIAGE IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#1306METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING PULSE DOSE CALCITRIOL
#1307Use of 25-hydroxy vitamin Dto improve vitality of animals
#1308Method of treating and preventing secondary hyperparathyroidism
#1309USE OF VITAMIN D RECEPTOR AGONISTS AND PRECURSORS TO TREAT FIBROSIS
#1310High dosage Vitamin D
#1311CONTROLLED RELEASE COMPOSITION CONTAINING A STRONTIUM SALT
#1312Oil-in-water emulsion lotion containing 22-oxa-1α, 25-dihydroxyvitamin Dand method of treatment of skin disorder using the same
#1313Methods and compositions for controlled release oral dosage of a vitamin D compound
#1314Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions
#1315METHOD FOR TREATING AND PREVENTING HYPERPARATHYROIDISM
#1316Vitamin preparation
#1317Compositions and methods for treating hyperproliferative epidermal diseases
#1318Methods and compositions for preventing and treating a disease related to glycan dysregulation
#1319COMPOSITION AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
#1320USE OF COMPOSITIONS TO ENHANCE INNATE IMMUNE RESPONSE
#1321Oral Compositions, Products and Methods Of Use
#1322Oral Compositions, Products And Methods Of Use
#1323ORALLY-DISPERSIBLE PHARMACEUTICAL COMPOSITIONS
#1324Formulation to prevent and treat fibromyalgia, depression and other muscle and nervous system disorders
#1325Compositions and Mehtods for Treating and Preventing Cancer Using Analogs of Vitamin D
#1326COMPOSITIONS AND METHODS OF TREATING CHRONIC KIDNEY DISEASE
#1327Composition and methods for skin care
#1328Peptides, derivatives and analogs thereof, and methods of using same
#1329Preparation for preventing or treating calcium deficiency conditions in mammals
#1330Method of Extending the Dose Range of Vitamin D Compounds
#1331Micronutrient formulations for pulmonary and heart health
#1332Nutritional supplement for women
#1333Compositions and methods for the treatment and/or prevention of osteoporosis
#1334Nutrient compositions and methods for enhanced effectiveness of the immune system
#1335Fatty acid formulations and methods of use thereof
#1336Method for treating benign prostatic hyperplasia
#1337Ex Vivo Gene Expression in Whole Blood as a Model of Assessment of Individual Variation to Dietary Supplements
#1338Soft gelatin capsules
#1339Compositions with modulating agents
#1340Nutrient composition(s) and system(s) for individualized, responsive dosing regimens
#1341PREVENTION OF OVARIAN CANCER BY ADMINISTRATION OF A VITAMIN D COMPOUND
#1342Carnosine-related compounds for preventing and treating impaired neurovascular blood flow
#1343Combination Medication for Treating the Effects of Stomach Acid Reduction Medication on Bone Integrity
#1344METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NEOVASCUALRIZATION
#1345Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof
#1346Methods for prophylactic and therapeutic nutritional supplementation
#1347Compositions and methods for nutrition supplementation
#1348New Use
#13492-ethyl and 2-ethylidene-19-nor-vitamin D compounds
#1350Pulmonary delivery of 1alpha,25-dihydroxyvitamin D3 and co-administration of parathyroid hormone or calcitonin
#1351Compositions comprising strontium and vitamin D and uses thereof
#1352VITAMIN D COMPOUNDS USED TO STABILIZE KIDNEY TRANSPLANTS
#1353INDUCTION OF INNATE IMMUNITY BY VITAMIN D3 AND ITS ANALOGS
#1354METHOD OF INHIBITING ALVEOLAR BONE RESORPTION AND PERIODONTAL MEMBRANE LOSS AND COMPOSITION FOR INTERNAL USE TO BE USED THEREIN
#1355STRONTIUM COMPOSITIONS FOR BONES
#1356Liquid Concentrated Formula
#1357Monohydrated sodium salt of S-tenatoprazole and the use thereof in therapy
#1358Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals
#1359Ed-71 preparation
#1360Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
#1361High-Potency Sweetener Composition with Calcium and Compositions Sweetened Therewith
#1362Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein
#1363METHOD OF USING CALCITRIOL FOR TREATING INTRAOCULAR DISEASES ASSOCIATED WITH ANGIOGENESIS
#1364Micronutrient supplement with calcium, vitamin D or calcium & vitamin D combination for premenstrual syndrome, postpartum depression, depression and panic attacks
#1365Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular disease
#13662-ethyl and 2-ethylidene-19-nor-vitamin D compounds
#1367Peptides, derivatives and analogs thereof, and methods of using same
#1368Methods for treating bladder dysfunction
#1369TREATMENT OF HYPERPROLIFERATIVE DISEASES USING HIGH DOSES OF ACTIVE VITAMIN D
#1370Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof
#1371Methods for prophylactic and therapeutic nutritional supplementation
#1372Nutritional supplement for women
#1373Prevention of ovarian cancer by administration of a vitamin D compound
#1374Compositions and methods for nutrition supplementation
#1375PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PSORIASIS
#1376Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions
#1377Method of preventing, medicating, and/or treating hypocalcemia of domestic mammal
#1378Nutrient system for individualized responsive dosing regimens
#1379Use of 2-methylene-19-nor-20(S)-1alpha,25dihydroxy vitamin d3 to inhibit mammary tumor
#1380Controlled release composition containing a strontium salt
#1381Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
#1382Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments
#1383Treatment of lung cancer with active vitamin D compounds in combination with other treatments
#1384Use of Vitamin D receptor activators or Vitamin D analogs to treat cardiovascular disease
#1385Compositions comprising vitamin k for treating or preventing age-related stiffening of arteries
#1386Shortening of hospital stay and improving survival in patients with chronic kidney disease
#1387Formulations useful against hepatitis C virus infections
#1388(20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
#1389Vitamin Dlactone derivatives
#1390Method of treating soild tumors and leukemias using combination therapy of vitamin D and anti-metabolic nucleoside analogs
#1391Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease
#1392Method of treatment of type I diabetes
#1393Use of inhibitors of 24-hydroxylase in the treatment of cancer
#1394Chewable tablet containing lysine
#1395Compositions for inducing of immunotolerance
#1396Compositions and methods for nutrition supplementation
#1397Compositions and methods for nutrition supplementation
#1398Compositions and methods for nutrition supplementation
#1399Pharmaceutical compositions comprising calcitriol and a clobetasol propionate
#1400Use of 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
#14012-ethyl and 2-ethylidene-19-nor-vitamin D compounds
#1402Cosmetic/dermatological inverse emulsions containing calcitriol and clobetasol 17-propionate
#1403Sprayable compositions comprising a combination of pharmaceutical active ingredients, an alcohol phase and an oily phase
#1404Sprayable compositions comprising a combination of pharmaceutical active agents, an alcohol phase, at least one volatile silicone and a non-volatile oily phase
#1405Compositions for treating or preventing cardiovascular disease
#1406Treatment of ICU-associated hypocalcemia with vitamin D compounds
#1407Composition comprising a combination of calcium, cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
#1408Method of treating solid tumors and leukemias using combination therapy of vitamin D and anti-metabolic nucleoside analogs
#1409Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
#1410Nutrient system for individualized responsive dosing regimens
#1411Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease
#1412Use of carbon-2-modified-19-nor-vitamin d analogs to induce the formation of new bone
#1413Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular disease
#1414Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin Dfor the prophylaxis of bone diseases
#1415(20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin Dand their uses
#1416Use of Vitamin Ds to treat kidney disease
#1417Methods for reducing body fat using vitamin D compounds
#1418Nutrient compositions and methods for enhanced effectiveness of the immune system
#1419Use of vitamin Ds to treat kidney disease
#1420Vitamin D analogs for obesity prevention and treatment
#1421Calcium formate for use as a dietary supplement
#14222-Alkylidene-19-nor-vitamin D derivatives for the treatment of hypocalcemic tetany or hypoparathyroidism
#1423Method of treating mammals with genistein and/or genistein analogues
#1424Treatment of inflammatory bowel disease with vitamin D compounds
#1425Pharmaceutical composition and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist
#14262-aklylidene-19-nor-vitamin D derivatives for the treatment of anorexia or low bone mass in females exhibiting aggressive athletic behavior
#1427Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an EP2 or EP4 selective agonist
#14282-alkylidene-19-nor-vitamin D derivatives for enhancement of peak bone mass in adolescence
#14292-Alkylidene-19-nor-vitamin D derivatives for the treatment of osteosarcoma
#1430Method for treating benign prostatic hyperplasia
#1431Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin Dto increase the life expectancy of human beings
#1432Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bone morphogenetic protein
#1433Use of vitamin D compounds
#1434Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen
#1435Compositions and methods for treating and preventing cancer using analogs of vitamin D
#1436Compositions and methods for preventing or treating eyestrain
#14372-Ethyl and 2-ethylidene-19-nor-vitamin D compounds
#14385,6-Trans-2-alkylvitamin D derivatives
#1439Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
#1440Testosterone enhancing compositions and methods
#1441Method and composition for an improved bioavailability delivery system
#1442Water soluble electrolyzed silicon dioxide formulation and method of manufacture
#1443Micronutrient composition to improve men's health
#1444Composition and method of treating conditions associated with extracellular matrix dysfunction by administering micronutrient composition
#1445Therapeutic method against viral infection
#1446Micronutrient combination to reduce blood pressure
#1447Composition and method for preventing long-term COVID-19 morbidity
#1448Pharmaceutical composition Mix A to treat health conditions associated with elevated glucose levels
#1449Pharmaceutical composition Mix B to treat health conditions associated with elevated glucose levels
#1450Compositions and methods for treating skin diseases, disorders, or conditions
#1451Transparent water nanolipid fluid (DNLF) dispersions and method of preparation using a twin screw extruder
#1452Alcohol metabolism acceleration composition
#1453Method of boosting immune system against viral infection
#1454Transparent colloidal vitamin supplement blend
#1455Transparent colloidal vitamin supplement
#1456Nutritional supplement
#1457Pharmaceutical composition for treating bacterial and viral infections
#1458Pharmaceutical composition for treating bacterial and viral infections
#1459Pharmaceutical composition for treating bacterial and viral infections
#1460Strontium-based composition, product, and method of using the same to control progression of osteoarthritis osteoporosis and tooth decay
#1461Diabetic nutritional composition
#1462Multi-purpose nutritional supplement composition
#1463Vitamin supplement compositions with enhanced bioavailability
#1464Method for treating azoospermia
#1465Effective, non-toxic treatments for brain cancer
#1466Composition for the treatment of acne
#1467Treatment for hair thinning and hair loss
#1468Compositions and methods of improving cognitive performance
#1469Agent and method for increasing testosterone level in a body
#1470Fat-soluble vitamin formulations